National Institute on Drug Abuse Clinical Trial Network Clinical Coordinating Center (NIDA CTN CCC)
To date, the efficacy of new treatments for drug addiction has been demonstrated primarily in specialized research settings, with somewhat restricted patient populations. To address this problem, the National Institute on Drug Abuse (NIDA) has established the National Drug Abuse Treatment (NDAT) Clinical Trials Network (CTN).
The mission of the CTN is to forge partnerships to improve the quality of drug abuse treatment nationwide. The objective of the CTN is twofold:
Participants with substance abuse enroll in behavioral, pharmacological, and integrated treatment intervention studies conducted at some of the 240 Community-based Treatment Programs (CTPs) associated with 16 regional nodes across the United States.
The CTN consists of 13 university centers (Nodes) that are associated with approximately 240 community treatment programs (CTPs).
Active clinical trials:
Five new protocols are currently under development. More information will be posted as information becomes available.